• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增强噻康唑的指甲传递:结合纳米胶囊制剂和指甲穿孔方法。

Enhancement of tioconazole ungual delivery: Combining nanocapsule formulation and nail poration approaches.

机构信息

Programa de Pós-graduação em Ciências Farmacêuticas, Universidade Federal de Santa Maria, Santa Maria, Brazil; Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom.

Department of Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom.

出版信息

Int J Pharm. 2018 Jan 15;535(1-2):237-244. doi: 10.1016/j.ijpharm.2017.11.008. Epub 2017 Nov 7.

DOI:10.1016/j.ijpharm.2017.11.008
PMID:29126904
Abstract

This work investigated the impact of formulation including in vitro release profile, repeated dosing, and nail poration on the ex vivo nail delivery performance of antifungal formulations. Chitosan coated and uncoated tioconazole-loaded nanocapsules and a nano-based film-forming vehicle were assessed via in vitro release and in vitro permeation tests using an artificial membrane and human nail clippings, respectively. The later involved single and daily dosing experiments with intact and porated nails. Additional experiments with Nile Red-loaded formulations evaluated the depth of penetration of the fluorescent marker into the nail by laser scanning confocal microscopy. The nanocapsule formulations prolonged release of tioconazole for longer than the control solutions and this ability was related to an enhanced nail penetration of the drug. Further, the new film-forming formulation delivered its drug payload more efficiently than a marketed product. Daily dosing of the formulations doubled the amount of drug recovered from the nails. Porating the nails enhanced tioconazole delivery in single dose experiments only. The depth of penetration of Nile Red into the nails clippings ranged between 90-160 μm. This research suggests that ensuring prolonged release of a drug is fundamental to develop efficacious topical nail formulations.

摘要

本研究考察了制剂配方(包括体外释放曲线、重复给药和指甲穿孔)对抗真菌制剂经皮给药性能的影响。通过体外释放和体外渗透试验,分别使用人工膜和人指甲片评估了壳聚糖包被和未包被的负载噻康唑纳米胶囊以及基于纳米的成膜载体。后者涉及完整和穿孔指甲的单次和每日给药实验。用尼罗红负载的制剂进行的额外实验通过激光扫描共聚焦显微镜评估了荧光标记物进入指甲的穿透深度。纳米胶囊制剂使噻康唑的释放时间延长,超过了对照溶液,并且这种能力与药物增强的指甲穿透性有关。此外,新的成膜制剂比市售产品更有效地输送其药物有效负载。每日给药制剂使从指甲中回收的药物量增加了一倍。在单次剂量实验中,仅穿孔指甲可增强噻康唑的递送。尼罗红进入指甲片的穿透深度在 90-160 μm 之间。这项研究表明,确保药物的持续释放是开发有效的局部指甲制剂的基础。

相似文献

1
Enhancement of tioconazole ungual delivery: Combining nanocapsule formulation and nail poration approaches.增强噻康唑的指甲传递:结合纳米胶囊制剂和指甲穿孔方法。
Int J Pharm. 2018 Jan 15;535(1-2):237-244. doi: 10.1016/j.ijpharm.2017.11.008. Epub 2017 Nov 7.
2
An innovative polysaccharide nanobased nail formulation for improvement of onychomycosis treatment.一种用于改善甲癣治疗的基于多糖纳米颗粒的创新型指甲制剂。
Eur J Pharm Sci. 2017 Mar 30;100:56-63. doi: 10.1016/j.ejps.2016.12.043. Epub 2017 Jan 5.
3
Optimized Ciclopirox-Based Eudragit RLPO Nail Lacquer: Effect of Endopeptidase Enzyme as Permeation Enhancer on Transungual Drug Delivery and Efficiency Against Onychomycosis.基于环吡酮胺的优化 Eudragit RLPO 指甲油:作为渗透增强剂的内肽酶对经皮药物递送和抗甲真菌病的效率的影响。
AAPS PharmSciTech. 2018 Apr;19(3):1048-1060. doi: 10.1208/s12249-017-0917-8. Epub 2017 Nov 14.
4
Novel nail penetration enhancer containing vesicles "nPEVs" for treatment of onychomycosis.用于治疗甲癣的新型含囊泡指甲渗透促进剂“nPEVs”
Drug Deliv. 2016 Oct;23(8):2813-2819. doi: 10.3109/10717544.2015.1099059. Epub 2015 Oct 8.
5
Novel topical formulations of Terbinafine-HCl for treatment of onychomycosis.盐酸特比萘芬的新型局部制剂治疗甲真菌病。
Eur J Pharm Sci. 2013 Mar 12;48(4-5):628-36. doi: 10.1016/j.ejps.2012.12.014. Epub 2013 Jan 4.
6
Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis: in vitro and in vivo evaluation.用于治疗甲癣的盐酸特比萘芬脂质体膜制剂:体外和体内评价
J Liposome Res. 2016;26(2):163-73. doi: 10.3109/08982104.2015.1067892. Epub 2015 Jul 30.
7
Precise laser poration to control drug delivery into and through human nail.精确激光穿孔控制药物递送入和穿过人指甲。
J Control Release. 2017 Dec 28;268:72-77. doi: 10.1016/j.jconrel.2017.10.014. Epub 2017 Oct 16.
8
Ciclopirox vs amorolfine: in vitro penetration into and permeation through human healthy nails of commercial nail lacquers.环吡酮与阿莫罗芬:市售指甲油对人健康指甲的体外渗透及透过情况
J Drugs Dermatol. 2014 Feb;13(2):143-7.
9
Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis.用于甲癣局部治疗的更安全无创经甲给药系统的设计与开发。
Drug Dev Ind Pharm. 2015;41(7):1095-9. doi: 10.3109/03639045.2014.931966. Epub 2014 Jul 1.
10
Development of ciclopirox nail lacquer with enhanced permeation and retention.开发具有增强渗透和滞留作用的环吡酮胺指甲油。
Arch Pharm Res. 2016 Jul;39(7):953-9. doi: 10.1007/s12272-016-0774-0. Epub 2016 Jun 15.

引用本文的文献

1
Nanocarriers in Ungual Drug Delivery.用于指甲给药的纳米载体。
Pharmaceutics. 2025 Aug 15;17(8):1060. doi: 10.3390/pharmaceutics17081060.
2
Penetration Profiles of Four Topical Antifungals in Mycotic Human Toenails Quantified by Matrix-Assisted Laser Desorption Ionization-Fourier Transform Ion Cyclotron Resonance Imaging.通过基质辅助激光解吸电离-傅里叶变换离子回旋共振成像定量分析四种外用抗真菌药在人类霉菌性趾甲中的渗透情况
Infect Dis Ther. 2024 Jun;13(6):1269-1279. doi: 10.1007/s40121-024-00978-3. Epub 2024 May 4.
3
New Formulation-Microporation Combination Approaches to Delivering Ciclopirox across Human Nails.
新型制剂-微针穿刺联合方法用于将环吡酮透过人指甲递送
Pharmaceutics. 2024 Jan 4;16(1):72. doi: 10.3390/pharmaceutics16010072.
4
Newer Therapies in Dermatophytosis.皮肤癣菌病的新型疗法
Indian J Dermatol. 2023 Sep-Oct;68(5):515-519. doi: 10.4103/ijd.ijd_829_23.
5
Non-dermal applications of microneedle drug delivery systems.微针药物递送系统的非皮肤应用。
Drug Deliv Transl Res. 2022 Jan;12(1):67-78. doi: 10.1007/s13346-021-00922-9. Epub 2021 Feb 24.
6
Recent Patents on Permeation Enhancers for Drug Delivery Through Nails.近期关于通过指甲进行药物递送的渗透促进剂的专利
Recent Pat Drug Deliv Formul. 2019;13(3):203-218. doi: 10.2174/1872211313666191030155837.
7
Recent advances in therapies for onychomycosis and its management.甲癣治疗及其管理的最新进展。
F1000Res. 2019 Jun 25;8. doi: 10.12688/f1000research.18646.1. eCollection 2019.
8
Novel Drug Delivery Strategies for the Treatment of Onychomycosis.治疗甲癣的新型药物递送策略
Pharm Nanotechnol. 2019;7(1):24-38. doi: 10.2174/2211738507666190228104031.